Details for New Drug Application (NDA): 212875
✉ Email this page to a colleague
The generic ingredient in CHLORTHALIDONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
Summary for 212875
Tradename: | CHLORTHALIDONE |
Applicant: | Tagi |
Ingredient: | chlorthalidone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 212875
Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for 212875
Suppliers and Packaging for NDA: 212875
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 212875 | ANDA | TAGI Pharma, Inc. | 51224-118 | 51224-118-50 | 100 TABLET in 1 BOTTLE (51224-118-50) |
CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 212875 | ANDA | TAGI Pharma, Inc. | 51224-118 | 51224-118-70 | 1000 TABLET in 1 BOTTLE (51224-118-70) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Feb 24, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription